What is Forensic Fluids?
Forensic Fluids Laboratories operates at the intersection of clinical diagnostics and forensic science, specializing in advanced oral fluid drug testing. The company provides a critical service to high-stakes sectors, including drug courts, educational institutions, mental health facilities, and military health systems. By delivering results within an 8 to 24-hour window, the firm addresses the urgent need for rapid, non-invasive, and accurate substance monitoring. Their service model emphasizes on-site convenience, which significantly reduces the logistical friction typically associated with traditional laboratory testing. Through the detection of both established substances and emerging designer drugs, Forensic Fluids has established itself as a vital partner for organizations requiring rigorous compliance and therapeutic monitoring solutions.
How much funding has Forensic Fluids raised?
Forensic Fluids has raised a total of $2M across 2 funding rounds:
Debt
$1M
Debt
$1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1M led by PPP
Key Investors in Forensic Fluids
PPP
Public-Private Partnership
What's next for Forensic Fluids?
With the recent infusion of capital, Forensic Fluids is poised to accelerate its technological roadmap and expand its footprint in the enterprise drug screening market. The strategic focus will likely center on enhancing laboratory throughput and integrating advanced analytical capabilities to detect a broader spectrum of therapeutic and illicit substances. As the regulatory landscape for drug testing evolves, the company's ability to provide rapid, on-site diagnostic data will be a key differentiator. Future growth initiatives are expected to prioritize the scaling of their service delivery model to accommodate larger institutional contracts, further solidifying their role as a leader in the diagnostic testing industry.
See full Forensic Fluids company page
